scispace - formally typeset
C

Charles Mady

Researcher at University of São Paulo

Publications -  326
Citations -  5472

Charles Mady is an academic researcher from University of São Paulo. The author has contributed to research in topics: Heart failure & Cardiomyopathy. The author has an hindex of 37, co-authored 314 publications receiving 5015 citations. Previous affiliations of Charles Mady include Houston Methodist Hospital & Federal University of Maranhão.

Papers
More filters
Journal ArticleDOI

Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity.

TL;DR: In Chagas' heart disease (CHD), MDE by MRI quantifies MF that not only can be detected in the early asymptomatic stages but parallels well-established prognostic factors and provides unique information for clinical disease staging.
Journal ArticleDOI

Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy.

TL;DR: It is concluded that 50% of the patients with heart failure due to Chagas' disease die in 47 months and that &OV0622;O2max and EF are important indices of survival in this group.
Journal ArticleDOI

Chronic Chagas' Disease Cardiomyopathy Patients Display an Increased IFN-γ Response to Trypanosoma cruzi Infection

TL;DR: The results suggest that CCC and ASY patients may respond differentially to the IFN-gamma-inducing stimulus provided by T. cruzi infection, and the ability to mount a vigorous IFN -gamma response may play a role on the differential susceptibility to CCC development.
Journal ArticleDOI

Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy.

TL;DR: It is suggested that aldosterone may contribute to the incidence of ventricular arrhythmia in patients with CHF, and spironolactone helps reduce this complication.
Journal ArticleDOI

Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients

TL;DR: In this article, the authors compared plasma tumor necrosis factor-alpha (TNF-alpha) levels among asymptomatic/indeterminate" Chagas disease patients (ASY) and patients across the clinical spectrum of chronic Chagga disease cardiomyopathy (CCC).